Respiratory infections in patients receiving Immune Checkpoint Inhibitors using the World Health Organization pharmacovigilance database - VigiBase - Vienna 2024

Advances in respiratory infection epidemiology: knowledge at the population scale

Chair(s): Natalia El-Merhie, Sabine Stadler

Session type: Poster session

Respiratory infections in patients receiving Immune Checkpoint Inhibitors using the World Health Organization pharmacovigilance database - VigiBase

Thomas Maitre

EVENTS HOME

Abstract

Previous presentation

Next presentation

Session content

The frequency of respiratory diagnoses was significantly higher for cases than for controls before the pandemic, a case-control study of all adults in Region Stockholm with a registered PASC diagnosis.

Pia Lindberg

Poster

Abstract

Rhinovirus (RhV) infection in hospitalised adults

Tommaso Morelli

Poster

Abstract

Is each flu season always the same?

Aycan Y?ksel

Poster

Abstract

Seasonality of respiratory viruses and viral co-infection across two winter seasons in the UK.

Martha Purcell

Poster

Abstract

RSV-associated clinical outcomes: A decade of insight from 52 million people across Europe

Katia Mc Verhamme

Poster

Abstract

Geographical differences in the airway microbiota of COPD patients across the UK

Hollian Richardson

Poster

Abstract

Evolution of S. pneumoniae serotype distribution in adults with CAP in Switzerland

Samuel Etienne

Poster

Abstract

Clinical characteristics of patients one year after hospitalisation for viral lower respiratory tract disease by viral aetiology: A descriptive US claims analysis

Malin Fageras

Poster

Abstract

Smoking and COVID 19 infection: What impact?

Hamida Kwas

Poster

Abstract

Epidemiology, burden and clinical course in RSV-infected older adults in the outpatient setting in Germany

Christopher Alexander Hinze

Poster

Abstract

Impact of respiratory syncytial virus (RSV) disease on the quality of life (QoL) of older adults in Europe

Desmond Curran

Poster

Abstract

Predictors, patterns and outcomes of Human Metapneumovirus in a hospitalized cohort.

Maraed Rosa

Abstract

Risk factors for community-acquired pneumonia in older adults after the introduction of childhood 13-valent pneumococcal conjugate vaccine: A multi-center case-control study in Japan

Naoki Inoshima

Poster

Abstract

Trends in Triazole Therapy and Mortality Rates Among Hospitalized Chronic Pulmonary Aspergillosis Patients: A Nationwide Observational Study in France

Thomas Maitre

Poster

Abstract

Respiratory infections in patients receiving Immune Checkpoint Inhibitors using the World Health Organization pharmacovigilance database - VigiBase

Thomas Maitre

Abstract

Severe COVID-19: how are these patients today

Sara Andreia G?is Morgado

Abstract

Nonalcoholic Fatty Liver Disease Increases the Risk of Lung Abscess: Findings from a Nationwide Cohort Study

Eunso Lee

Abstract

Health-care resource use and cost one year after hospitalisation among patients admitted with viral lower respiratory tract disease by viral aetiology: A descriptive US claims analysis

Susan Johnson

Poster

Abstract

Health-care resource utilisation and cost one year after hospitalisation among patients hospitalised with viral lower respiratory tract disease: A descriptive US claims analysis

Ekaterina Maslova

Poster

Abstract

The association between time-weighted remnant cholesterol and respiratory-related mortality: A population-based cohort study

Gary Tse

Poster

Abstract

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}